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We demonstrate here that the Src family kinase Lyn nega-
tively regulates Toll-like receptor (TLR) signaling in bone
marrow-derived macrophages (BMMΦs) and in vivo. Lyn-
/- BMMΦs produced and secreted significantly more IL-6,
TNF-α, and IFN-α/β compared to WT BMMΦs, indicating
that Lyn is able to control both MyD88- and TRIF-depend-
ent signaling pathways downstream of TLR4. CD14 was
not involved in this type of regulation. Moreover, Lyn
attenuated proinflammatory cytokine production in
BMMΦs in response to the TLR2 ligand, FSL-1. In agree-
ment with these in vitro experiments, Lyn-deficient mice
produced higher amounts of proinflammatory cytokines
than WT mice after i. v. injection of LPS or lipopeptide.
Though Lyn clearly acted as a negative regulator down-
stream of TLR4, it did not, different to what was proposed
previously, alter the process of LPS tolerance. Stimulation
with a low dose of LPS resulted in reduced production of
proinflammatory cytokines after a subsequent stimula-
tion with a high dose of LPS in both WT and Lyn-/-
BMMΦs as well as in vivo. Mechanistically, Lyn interacted
with PI3K and in correlation, PI3K inhibition resulted in
increased LPS-triggered cytokine production. In this line,
SHIP1-deficient BMMΦs, exerting enhanced PI3K-path-
way activation, produced less cytokines compared to WT
BMMΦs. In conclusion, Lyn is a negative regulator of TLR-
induced cytokine production in vitro and in vivo and acts,
at least in part, via PI3K.
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